M itochondria and the endoplasmic reticulum (ER) are separately considered key players in cell death signaling.
M itochondria and the endoplasmic reticulum (ER) are separately considered key players in cell death signaling. 1 Mitochondria and ER are interconnected organelles and form an endomembrane network. The contact points through which ER communicates with mitochondria are referred to as mitochondria-associated membranes (MAM). 2 MAM are enriched in phospholipid-and glycosphingolipid-synthesis enzymes, as well as chaperone proteins, which transport lipids and exchange calcium between these 2 organelles. 1 Several recent studies have identified new proteins enriched at the ER-mitochondria interface, highlighting the emerging understanding of the role of this region within the cell. 3, 4 One of them has identified a macromolecular complex composed of VDAC1, Grp75, and IP3R1 that regulates direct Ca 2+ transfer from ER to mitochondria. 5 Indeed, ER-mitochondria junctions are aligned with mitochondrial contact points where VDAC1 is abundantly present, thus creating a hot spot for the Ca 2+ transfer from the ER. 6 Although the role of this organelle cross talk is beginning to be understood in cell physiology, MAM involvement in cardiac pathologies remains unknown.
Clinical Perspective on p 1565
Calcium signaling is central for heart function through its physiological role in excitation-contraction coupling and the detrimental impact of Ca 2+ overload during heart failure and myocardial ischemia/reperfusion. During this latter condition, it is well accepted that the cytosolic accumulation of Ca 2+ subsequently results in mitochondrial Ca 2+ overload,
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which activates the matrix chaperone cyclophilin D (CypD) and triggers the opening of the permeability transition pore (PTP), leading to cell death. 7 Recent reports have confirmed the existence of Ca 2+ microdomains between ER and mitochondria in the myocardium, where the organization of the network between the 2 organelles is highly ordered. 8, 9 It has also been suggested that mitochondrial Ca 2+ overload could be mediated through IP3R. 10 We therefore questioned whether Ca 2+ transfer from ER to mitochondria via the VDAC1/Grp75/IP3R1 complex might play a role in mitochondrial Ca 2+ overload and subsequent cardiomyocyte death observed during the reperfusion phase after a sustained ischemic insult. We further questioned the relationship between CypD and VDAC1/Grp75/ IP3R1 complex in the regulation of the Ca 2+ exchange during ischemia/reperfusion. We report a new physiological role of CypD in ER-mitochondria Ca 2+ exchange via its interaction with the VDAC1/Grp75/IP3R1 complex, with major impact on cardiomyocyte death on hypoxia-reoxygenation (HR).
Methods
For further details, see Methods in the online-only Data Supplement.
Animals
Ppif −/− mice under C57Bl6/SV129 background were a gift from S.J. Korsmeyer's laboratory (Dana Farber Cancer Institute, Boston, MA). 11 Both wild-type (WT) and Ppif −/− male mice were obtained by homozygous intercross in our laboratory. All experiments were performed on mice at 8 weeks. All procedures conformed to European Parliament Directive 2010/63/EU and the September 22, 2010 Council on the Protection of Animals and were approved by the local institutional animal research committee (No. BH2012-64).
Duolink Proximity Ligation In Situ Assay
Cells were fixed with 4% paraformaldehyde (10 minutes at room temperature) and permeabilized with the use of 0.1% Triton X-100 (15 minutes at room temperature). Subsequent blocking, antibody hybridizations, proximity ligations, and detections were performed according to recommendations from manufacturers (OLINK Bioscience). The cells were incubated with the primary antibodies overnight at 4°C and then washed 3 times with TBS-0.05% Tween 20. Briefly, after incubation with primary antibodies, we applied combinations of corresponding in situ proximity ligation assay (PLA) probes for 1 hour at 37°C. The cells were washed with TBS-0.05% Tween 20, incubated for 30 minutes with ligase, and finally washed with TBS-0.05% Tween 20. Then cells were incubated with polymerase for 100 minutes. Finally, the cells were washed once with saline-sodium citrate 1× and then with saline-sodium citrate 0.1×. All reactions were performed at 37°C in a humid chamber with 30 µL of reaction mixture per well. Preparations were mounted in Duolink II mounting medium containing DAPI (Eurogentec). Fluorescence was analyzed with a Zeiss inverted fluorescent microscope equipped with an ApoTome, with the use of the AxioVision program.
Quantification of signals was performed with BlobFinder software (Center for Image Analysis, Uppsala University) and expressed as interactions per cell relative to the nontreated group. Experiments were performed at least 3 times, with a minimum of 5 fields taken per condition. 
Ca
2+ Measurements in H9c2 Cells
Isolation of Adult Murine Cardiomyocytes and Ca
2+ Measurements
Ventricular cardiomyocytes were isolated with the use of enzymatic digestion according to a previously described procedure.
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Cardiomyocytes were loaded for 20 minutes at 37°C with Fluo4-AM (5 µmol/L; Invitrogen). To measure Ca 2+ transients, cardiomyocytes were field-stimulated at 1 Hz with a current pulse delivered via 2 platinum electrodes. Changes in Fluo4 fluorescence were recorded at 25°C with the use of an LSM510 Meta confocal microscope equipped with a ×63 water-immersion objective (numeric aperture=1.2; line-scan mode=1.5 ms per line; Zeiss). Scanning was performed along the long axis of the cell.
To measure mitochondrial Ca
2+
, cardiomyocytes were loaded for 40 minutes at 37°C with Rhod2-AM (5 µmol/L; Teflabs, Austin, TX). Cardiomyocytes were stimulated under action potential-induced clamp conditions with the use of a whole-cell patch-clamp technique at room temperature with an Axopatch 200B (Axon Instruments), as described previously.
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Cellular Model of HR and Analysis of Cell Death and Mitochondrial Ca 2+ Concentration
H9c2 cardiomyoblasts were subjected to 3 hours of hypoxia followed by 2 hours of reoxygenation at 37°C. Cells were randomized to receive either no additional intervention (HR group), 1 µmol/L NIM811 (HR+NIM811 group), or 50 µmol/L 2-APB (HR+2-APB group), administered at the onset of reoxygenation. To simulate hypoxia, the cell culture medium was replaced with Tyrode solution containing the following (in mmol/L): 130 NaCl, 5 KCl, 10 HEPES, 1 MgCl 2 , 1.8 CaCl 2 at pH 7.4/37°C; cardiomyoblasts were exposed to hypoxia in a controlled hypoxic chamber (Adelbio; Clermont-Ferrand, France) by 95% nitrogen and 5% CO 2 gas mixture flushing up to partial O 2 pressure of 0.5% to 1%. Reoxygenation was conducted in a normoxic incubator at 37°C by replacing the ischemia medium for 2 hours with DMEM supplemented with 10% FBS. The time control group consisted of cells without the hypoxic stimulus kept in the reoxygenation buffer. Cell death was determined after loading with 1 µg/mL propidium iodide, which permeates only the damaged cells, and was measured by flow cytometry (FACSCalibur, BD) at the end of the 2-hour reoxygenation period. A similar protocol was used for isolated adult cardiomyocytes except that the duration of hypoxia was reduced to 45 minutes and cell death was measured by counting propidium iodide-positive cells with the use of microscopy after the 120-minute reoxygenation period. For mitochondrial Ca 2+ concentration measurements, H9c2 cells were loaded before hypoxia with Rhod2 as described above, and fluorescence measurement was determined by a fluorescence plate reader (Fluoroskan Ascent, Thermo Scientific) at an excitation wavelength of 542 nm and an emission wavelength of 590 nm. Intensity was normalized by cell density measured with Crystal Violet staining. appropriate multiple testing procedure was performed. For all other analysis, data were compared by the Mann-Whitney rank sum test. Statistical significance was defined as a value of P<0.05.
Results
CypD Interacts With the VDAC1/Grp75/IP3R1 Ca
2+
Channeling Complex in the Heart
We first questioned whether CypD could be present at the heart MAM interface by adapting the protocol of MAM isolation from the liver to the heart. 14 Absence of crosscontamination and purity of each fraction was assessed by both electron microscopy ( Figure I in the online-only Data Supplement) and Western blot ( Figure 1A ). As expected, CypD was concentrated in pure mitochondria and absent in the ER. However, a small fraction of CypD was also detected in the MAM fraction, together with IP3R1, Grp75, and VDAC1. To determine whether these proteins could form a macromolecular complex, we performed 2-dimensional blue native polyacrylamide gel electrophoresis separation of heart homogenates. CypD was present in varying amounts in complexes that have a wide range of sizes but more particularly in a high-molecular-weight complex in which VDAC1, Grp75, and IP3R1, but not ANT, were detected ( Figure 1B) . A specific interaction of CypD with the IP3R1 channeling complex was also demonstrated by IP3R1 immunoprecipitation in mice heart homogenates ( Figure 1C ). To further confirm the involvement of CypD in the IP3R1 channeling complex, we monitored in situ protein-protein interactions at the MAM interface by proximity ligation assay in H9c2 cardiomyoblasts. We observed the interaction between IP3R1 and VDAC1, with Grp75 as an intermediate ( Figure 1D , first row). To evaluate the potential involvement of CypD in this complex, we analyzed the interactions between IP3R1 and CypD, as well as with Grp75. For each couple of proteins, red fluorescent dots were observed, illustrating interactions of IP3R1 and Grp75 with CypD ( Figure 1D , middle row). Interestingly, no interaction was observed between CypD and other ER Ca 2+ channeling proteins, such as Serca2 and RyR2, or with IP3R2 ( Figure 1C, last row) . This suggests that the CypD interaction with the VDAC1/Grp75/IP3R1 complex is specific and occurs at the ER-mitochondria interface ( Figure II in the online-only Data Supplement).
CypD Removal From the ER-Mitochondria Interface Decreases the Interactions of Partner Proteins Within the VDAC1/Grp75/IP3R1 Complex
CypD is known to be a mitochondrial matrix protein able to be recruited at the inner membrane. To understand the role of CypD in the MAM, we performed at different time points (30 minutes, 2 hours, and 16 hours) a pharmacological inhibition of CypD in H9c2 cells. We used NIM811, a specific inhibitor homogenate; MAM, mitochondria-associated membranes; and pM, pure mitochondria. Serca2 and IP3R1 were used as ER markers, and VDAC1, Grp75, ANT, COX IV, and cytochrome c (cyt c) were used as mitochondrial markers. B, Twodimensional blue native (BN) separation of native heart extracts from wild-type mice. The blue native polyacrylamide gel electrophoresis (PAGE) was calibrated on the basis of the location of the mitochondrial respiratory chain complexes isolated from mouse heart mitochondria, separated by electrophoresis simultaneously with the total mouse heart lysate. CypD was present in varying amounts in complexes that have a wide range of sizes but more particularly in a high-molecularweight complex in which VDAC1, Grp75, and IP3R1, but not ANT, were detected (see arrow). C, Immunoprecipitation (IP) of IP3R1 from mice heart homogenates specifically pulled down CypD, as well as VDAC1 and Grp75. D, Visualization of in situ interactions between CypD, VDAC1, Grp75, and IP3R1 with the use of proximity ligation assay in H9c2 cells. Nuclei appear in blue, and interactions between the 2 proteins are depicted in red. of CypD (known to detach it from the inner mitochondrial membrane), 15 to determine whether it might change this protein localization in the MAM of H9c2 cells. As shown in Figure 2A and 2B, NIM811 treatment significantly decreased the interactions between CypD and IP3R1 after 2 and 16 hours with a time-dependent effect. Interestingly, inhibition of CypD by NIM811 also modified the interaction between the other partner proteins of the complex; indeed, Grp75/IP3R1 interactions were reduced as soon as 30 minutes after NIM811 treatment ( Figure 2C ), whereas interactions between Grp75 and VDAC1 diminished only after 2 hours of NIM811 treatment ( Figure 2D ).
In agreement with this, adult cardiomyocytes of Ppif −/− (CypD protein, mice null for the Ppif gene) mice displayed significantly decreased interactions of both VDAC1 and Grp75 with IP3R1 ( Figure 2E and 2F). We further analyzed the composition of heart MAM after the in vivo administration of either NIM811 or cyclosporin A in mice. Interestingly, NIM811 significantly decreased the presence of the chaperones CypD and Grp75 at the MAM interface, with a similar trend for cyclosporin A ( Figure 2G and 2H).
Alternatively, the inhibition of IP3R by either 2-APB or XestoC also decreased the interactions of IP3R1 with CypD and Grp75 ( Figure III in the online-only Data Supplement).
CypD Controls the Ca 2+ Transfer From ER to Mitochondria Through IP3R1
Given that the VDAC1/Grp75/IP3R1 complex has been shown to directly control the Ca 2+ transfer from ER to mitochondria, 5 we hypothesized that CypD would play a role in this Ca 2+ exchange between the 2 organelles. Assessment of specific mitochondrial Ca 2+ loading with Rhod2 was performed on H9c2 cells after histamine stimulation, which is known to induce Ca 2+ release from ER stores ( Figure 3A ). In untreated H9c2, histamine rapidly increased mitochondrial Ca 2+ levels, reflecting IP3R-mediated Ca 2+ transfer from ER to mitochondria. Both the downregulation of CypD expression by specific short interfering RNA (siRNA) and the pharmacological inhibition of CypD by NIM811 led to a nonsignificant reduction of the amplitude of the histamine-stimulated increase of mitochondrial Ca 2+ compared with control ( Figure To confirm the involvement of CypD in this Ca 2+ coupling in the heart, we examined Ca 2+ transients in isolated adult cardiomyocytes from WT and Ppif −/− mice. In adult Ppif −/− cardiomyocytes, the electrically evoked Ca 2+ transients displayed an unchanged rate of rise, a significantly reduced amplitude, and an increased time constant of decay ( Figure 4A through 4D). Caffeine stimulation revealed a reduction in the sarcoplasmic reticulum (SR) Ca 2+ load without any change of the rate of Ca 2+ release ( Figure 4E ). Importantly, these alterations of Ca 2+ homeostasis were mimicked by pharmacological inhibition of CypD activity with NIM811 in isolated WT cardiomyocytes ( Figure 4A through 4E) .
To confirm the involvement of CypD in vivo in the Ca 2+ transfer from SR to mitochondria, we measured mitochondrial Ca 2+ load by Rhod2 in isolated cardiomyocytes from WT and Ppif −/− mice under patch-clamp conditions ( Figure 4F ). Ppif −/− cardiomyocytes exhibited a significant reduction of mitochondrial Ca 2+ loading after both action potentialinduced Ca 2+ transients and caffeine-induced SR Ca 2+ release ( Figure 4G and 4H) . Altogether, these data strongly suggest that CypD is involved in the SR-mitochondria Ca 2+ coupling in the heart through the VDAC1/Grp75/IP3R1 complex. This SR-mitochondria Ca 2+ coupling may also contribute to modulate the global Ca 2+ homeostasis and excitation-contraction coupling in cardiomyocytes.
Inhibiting the CypD/VDAC1/Grp75/IP3R1 Complex Protects From HR Injury
On the basis of these results, we hypothesized that the IP3R1-dependent Ca 2+ transfer could also play a role in the mitochondrial Ca 2+ overload observed during ischemia/reperfusion and thus may be a new pharmacological target to prevent ischemia/reperfusion injury. HR of H9c2 led to a significant increase of the interactions between CypD, Grp75, and IP3R1, as revealed by in situ PLA ( Figure 5A and 4B and Figure VI in the online-only Data Supplement). These increased protein-protein interactions were associated with a higher mitochondrial Ca 2+ load ( Figure 5C ) and a significant increase of cell death compared with time control cells ( Figure 5D ). Interestingly, treatment at reoxygenation with either 2 µmol/L Under baseline conditions (time control), the downregulation of Grp75 significantly reduced the Grp75-IP3R1 interactions and tended to reduce the CypD-IP3R1 interactions and caused a decrease of the mitochondrial Ca 2+ load ( Figure 6A through 6C). After HR, Grp75-silenced H9c2 cells showed a decreased interaction of CypD and Grp75 with IP3R1 and a prevention of the increase in mitochondrial Ca 2+ content compared with control ( Figure 6A through 6C) . Cell death was significantly reduced after HR in the siGrp75 group. These results support the idea that modifying the CypD/VDAC1/Grp75/IP3R1 complex at reoxygenation prevents the Ca 2+ transfer from ER to mitochondria during HR and attenuates mitochondrial Ca 2+ loading and subsequent lethal cell injury.
Downregulation of Mfn2 Protects H9c2 Cells From Lethal HR Injury
Mfn2 has been recently shown to be involved in the tethering of ER to mitochondria and to regulate cardiac bioenergetics at the MAM interface. 3, 8 Downregulation of Mfn2 reduced the interactions between both CypD and VDAC1 with IP3R1 at baseline but also after HR ( Figure 7A ). In addition, downregulation of Mfn2 prevented the increase of the mitochondrial Ca 2+ content observed after HR ( Figure 7B) . Eventually, cells depleted in Mfn2 were protected against lethal HR injury ( Figure 7C ). These data support the proposal that decreasing the ER-mitochondria tethering protects from HR injury by reducing the IP3R1-mediated ER-mitochondria Ca 2+ transfer.
Protection of Adult Mice Cardiomyocytes From Lethal Reoxygenation Injury by Targeting the CypD/VDAC1/Grp75/IP3R1 Complex
The organization of the ER/SR and mitochondria is more complex in cardiomyocytes than in H9c2 cells. We then determined whether we could make similar observations in adult WT and Ppif −/− primary cardiomyocytes. Cardiomyocytes were subjected to 45 minutes of hypoxia followed by 2 hours of reoxygenation. In WT cardiomyocytes, the analysis of the interaction of both CypD and VDAC1 with IP3R1 by in situ PLA showed that HR significantly increased the interaction between the partners of the IP3R1 Ca 2+ channeling complex, concomitant with 45% of cell death as assessed by propidium iodide staining ( Figure 8A through 8C ), in agreement with our data in H9c2 cells. Treatment at reoxygenation with 1 µmol/L NIM811 significantly reduced the interaction between VDAC1 and IP3R1 and tended nonsignificantly to reduce the CypD/IP3R1 interactions while significantly decreasing HR-induced cell death ( Figure 8A through 8C) . Importantly, Ppif −/− cardiomyocytes displayed a significant reduction of both VDAC1/IP3R1 and Grp75/IP3R1 interactions after HR, concomitant with reduced cell death ( Figure 8D and 8E).
Discussion
We report that the mitochondrial chaperone CypD modulates ER-mitochondria Ca 2+ cross talk via the VDAC1/Grp75/ IP3R1 complex. This modulation plays an important role in HR injury. Pharmacological or genetic inhibition of each partner of the complex modified the Ca 2+ fluxes and blunted lethal reoxygenation injury. Decreasing the tethering of ER to mitochondria by downregulation of Mfn2 also prevented mitochondrial Ca 2+ overload and reduced cell death after HR injury. These findings provide new insights into the mechanism of lethal myocardial ischemia/reperfusion injury and open new therapeutic perspectives.
Recently, several MAM-specific proteins were identified, including Mfn2, PACS2, σ-1 receptor, and promyelocytic leukemia. 3, 4, 16, 17 Most of these proteins are ER proteins, with only a few (eg, Mfn2) belonging to mitochondria. The identification of CypD in close contact with the VDAC1/Grp75/ IP3R1 complex adds a new member to the list of mitochondrial partners in MAM. Several of these MAM-specific proteins are Ca 2+ -sensitive chaperones. 5 Interestingly, CypD is a Ca 2+ -sensitive mitochondrial chaperone and belongs to the peptidyl-prolyl cis-trans isomerase family, confirming the important role of this class of proteins to regulate Ca 2+ signaling at ER-mitochondria contact sites. Whether the chaperone activity of CypD is important for its interaction with the VDAC1/Grp75/IP3R1 complex was not specifically addressed in this study. Nevertheless, we found that pharmacological inhibition or siRNA removal of CypD altered the interaction among the other proteins of the VDAC1/Grp75/ IP3R1, suggesting that the link between CypD and the complex might not only be functional but also structural. One cannot, however, rule out that the predominant matrix fraction of CypD might also play a role in Ca 2+ transfer from the ER to mitochondria. The mechanism by which CypD physically and functionally interacts with the VDAC1/Grp75/ IP3R1 Ca 2+ channeling complex needs further investigation. However, its inhibition by NIM811, known to detach CypD from the mitochondrial membrane, suggests that its binding to the inner membrane is required to modulate the Ca 2+ flux from ER to mitochondria through the VDAC1/Grp75/IP3R1 complex. The observation that, under normoxic conditions, CypD facilitates the transfer of Ca 2+ from ER to mitochondria is in agreement with the well-known role of Ca 2+ in cardiac excitation-contraction coupling and bioenergy coupling between ER and mitochondria. Smaili et al 18 have suggested, in intact hepatocytes, a role of cyclophilins in the Ca 2+ cycling between ER and mitochondria by showing that cyclosporine modifies the IP3-dependent Ca 2+ signals. The present data expand this notion because both genetic and pharmacological inhibition of CypD leads to a decreased Ca 2+ transfer from ER to mitochondria through IP3R1, even in the in vivo cardiomyocyte model. IP3R exists as 3 isoforms. Different studies suggest that several isoforms of IP3R could be enriched in the MAM. 5, 19, 20 In the heart, the type-1 isoform of IP3R is highly expressed, but IP3R isoform 2 is recognized as the predominant isoform in the cardiac myocyte. 21 However, most of the functions of IP3Rs are attributed to the type-1 isoform, 22 and our results show that CypD preferentially interacts with IP3R isoform 1 because no interaction with IP3R isoform 2 was observed. One can wonder whether the impact of IP3R signaling plays an important role in the heart compared with the cardiac RyR2, which is the major Ca 2+ release channel on the SR in cardiomyocytes. In fact, accumulating evidence suggests that the IP3Rs, and more particularly the type 1 isoform, are involved in cardiac calcium signaling including the excitation-contraction and excitation-transcription coupling in the normal heart but also in some pathologies such as hypertrophy. 21, [23] [24] [25] [26] One may question whether other factors, including mitochondrial membrane potential or SR Ca 2+ load, might contribute to attenuate Ca 2+ transfer from ER to mitochondria on inhibition of CypD. In contrast to Smaili et al, 18 we found that inhibition of CypD by NIM811 did not modify the mitochondrial membrane potential, indicating that the observed reduction of Ca 2+ transfer from ER to mitochondria was likely not the result of a diminution of the driving force between the 2 organelles. After both the chronic (Ppif −/− ) and acute (NIM811) inhibition of CypD, we showed that cardiomyocytes exhibited a slower cytosolic Ca 2+ transient decay ( Figure 4A ), indicative of a slower SR Ca 2+ uptake, which in turn may explain the observed reduction in SR Ca 2+ content ( Figure 4E ). The reduction in SR Ca 2+ content can by itself explain the reduction in SR Ca 2+ transient ( Figure 4A and 4B) because the RyR2-dependent release process does not seem to be affected ( Figure 4D ). One may question whether the reduced SR 
Ca
2+ content may further contribute to the limitation in SR to mitochondria Ca 2+ transfer. Such a mechanism remains to be investigated in depth in future studies. In summary, we propose that the inhibition of CypD by first limiting the Ca 2+ transfer from SR to mitochondria through the VDAC1/Grp75/ IP3R1 complex might create a metabolic uncoupling between SR and mitochondria, which subsequently results in a deficient uptake of Ca 2+ by SR, possibly contributing to the disturbances in Ca 2+ homeostasis. Elrod et al 27 recently reported that cyclosporine could increase Ca 2+ uptake by mitochondria. This apparent discrepancy with our results may be attributable to different experimental preparations and techniques of Ca 2+ measurements. Elrod et al used pericam to measure mitochondrial Ca 2+ in neonatal rat cardiomyocytes, whereas we used Rhod2 either in H9c2 cardiomyoblasts or in adult mouse cardiomyocytes. Mitochondrial Ca 2+ was measured after singlepulse field stimulation by Elrod et al, whereas we also used histamine stimulation of IP3R, meaning that we, but not Elrod et al, specifically addressed the transfer of Ca 2+ from ER to mitochondria through the VDAC/Grp75/IP3R1 complex. Estimation of the efficiency of mitochondrial Ca 2+ uptake would have required that we had simultaneously measured cytosolic and mitochondrial calcium; it would have still been difficult to separate the effect of CypD inhibitors on either its energetic or calcium channeling properties.
On ischemia and reperfusion, the accumulation of Ca 2+ into mitochondria can trigger PTP opening and cell death. 28 Ca 2+ cross talk between ER and mitochondria has been involved in myocardial reperfusion injury. 29 We hypothesized that at least part of the death signal represented by mitochondrial Ca 2+ overload would come from the ER and that what we had observed under normoxic conditions would be of significant relevance for the challenge of HR injury. The interactions among all of the partners of the CypD/VDAC1/Grp75/ IP3R1 complex were significantly increased after HR and associated with mitochondrial Ca 2+ overload and cell death. Pharmacological inhibition of CypD by NIM811 administered at the time of reoxygenation prevented the increased interaction between the partners of the IP3R1 Ca 2+ channeling complex and attenuated the mitochondrial Ca 2+ overload. This suggests that the enhanced contact between ER and mitochondria and the subsequent increased transfer of Ca 2+ through the VDAC1/Grp75/IP3R1 complex during reoxygenation after a prolonged hypoxic insult may contribute to lethal cardiomyocyte injury. Obviously, one may object that the reduction of cell death after inhibition of CypD was attributable to the sole inhibition of PTP opening within mitochondria. Although this point is difficult to clarify because CypD-independent inhibitors of PTP would also reduce mitochondrial Ca 2+ overload and cell death, different observations are against this proposal. First, the pharmacological inhibition or genetic ablation of CypD caused disturbances in ER Ca 2+ homeostasis even under normoxic conditions (ie, when the PTP is not formed). Second, the mitochondrial CypD is located at the matrix under normoxic conditions and needs to be translocated to the inner membrane to trigger PTP opening on HR. In contrast, it appears that the subfraction of CypD located at MAMs is already bound to the VDAC1/ Grp75/IP3R1 complex under normoxic conditions. The reason for that is unclear; however, one may hypothesize that the likely high local concentration of Ca 2+ in the vicinity of the mitochondrial side of the VDAC1/Grp75/IP3R1 channel favors the binding of local CypD to the inner mitochondrial membrane. Third, we demonstrated that the inhibition of CypD reduced the number of CypD/VDAC1/Grp75/IP3R1 complexes formed during HR and significantly attenuated Ca 2+ accumulation into mitochondria. Most importantly, non-CypD-related reduction of ER-mitochondria interactions by pharmacological inhibition of IP3R or genetic loss of function of either Grp75 or Mfn2 produced comparable effects to inhibition of CypD in terms of reduction of Ca transfer from ER to mitochondria and (2) the downstream prevention of PTP formation via the limitation of CypD binding to the inner mitochondrial membrane. This is consistent with a previous report suggesting that Ca 2+ cycling from ER to mitochondria may directly favor the PTP. 30 This is also in agreement with reports showing that some modulators of apoptosis act by modifying Ca 2+ transfer from ER to mitochondria and subsequent PTP opening. 4, [31] [32] [33] In summary, our work identifies a new role for CypD as a partner of the VDAC1/Grp75/IP3R1 complex at the contact sites between ER and mitochondria, contributing to the Ca 2+ cross talk between the 2 organelles. It shows that this Ca 2+ transfer complex plays a major role in lethal reoxygenation injury and thereby identifies new molecular targets for cardioprotection. 
CLINICAL PERSPECTIVE
Our clinical group recently demonstrated via proof-of-concept clinical trials that both ischemic and pharmacological postconditioning (with the use of cyclosporine, an inhibitor of the opening of the mitochondrial permeability transition pore) reduced infarct size and improved long-term functional recovery in patients undergoing myocardial infarction. However, there is still an obvious need for new therapeutics to prevent myocardial damage in acute ischemic syndromes. Accumulating evidence suggests that mitochondria-sarcoplasmic reticulum interactions are relevant to the adult heart despite the complex and distinctive arrangement of mitochondria and reticulum in this organ. Indeed, the interactions of these 2 organelles are involved in local Ca 2+ exchange and therefore in the control of the fate of cardiomyocytes and excitation-contraction coupling in the heart. In the present study, we demonstrated a new role for cyclophilin D, a well-known regulator of the mitochondrial permeability transition pore opening, in the modulation of Ca 2+ exchange between mitochondria and sarcoplasmic reticulum via the IP3 receptors during hypoxia-reoxygenation. Furthermore, we showed that decreasing these functional contact points between mitochondria and sarcoplasmic reticulum at the level of the IP3 receptor Ca 2+ channeling complex protected cardiomyocytes by preventing mitochondrial Ca 2+ overload and cell death. These results suggest that the mitochondria-reticulum interface may be a new target to reduce infarct size after myocardial ischemia. These results are promising for the development of new therapeutics to attenuate lethal reperfusion injury after myocardial infarction. Under baseline conditions, physiological Ca 2+ transfer from the reticulum to mitochondria occurs through the VDAC1/Grp75/IP3R1 complex which might be regulated by CypD. Ischemia-reperfusion stress leads to an increased formation of IP3R1 complexes, favoring mitochondrial Ca 2+ overload and possibly cell death through PTP opening.
CypD is present at the IP3R1 complex and also recruited upon reperfusion at the PTP. Beyond the direct inhibition of PTP opening, cardioprotection could be induced by preventing mitochondrial Ca 2+ overload (and subsequent opening of the PTP) either through the inhibition of the partners of the IP3R1 Ca 2+ channeling complex (including CypD) or by decreasing reticulum-mitochondria tethering. 
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